TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has provided an update.
Imricor Medical Systems, Inc. announced a change in the interests of its director, Mr. Mark Tibbles, involving the disposal of 170,000 shares through an on-market trade and 73,380 shares via an off-market transfer. This adjustment in shareholding reflects a strategic decision by the director, potentially impacting the company’s stock dynamics and signaling a shift in personal investment strategy.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.28 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on the development and commercialization of magnetic resonance imaging (MRI)-guided cardiac ablation products. The company’s primary market focus is on providing innovative solutions for cardiac procedures, leveraging MRI technology to enhance precision and outcomes.
Average Trading Volume: 436,979
For an in-depth examination of IMR stock, go to TipRanks’ Stock Analysis page.